Laura E Miller1. 1. University of Tennessee, 293 Communications Building, Knoxville, TN 37996, USA. lmille41@utk.edu
Abstract
PURPOSE: Previous research has demonstrated the common experience of illness-related uncertainty; however, little research has explored the specific sources of uncertainty throughout cancer survivorship. The purpose of this study is to investigate the experience of uncertainty for cancer survivors and their partners. Thus, the following research question is posed: What are the sources of uncertainty in cancer survivorship for survivors and partners? METHOD: One-on-one interviews were conducted with 35 cancer survivors and 25 partners. Constant comparative methodologies were used to analyze the data. RESULTS: Participants described medical, personal, and social sources of uncertainty that persisted throughout survivorship. Medical sources of uncertainty included questions about the cancer diagnosis, treatment and prognosis. Personal sources of uncertainty included ambiguous valued identities and career-related questions. Social sources of uncertainty included unclear communicative, relational and familial consequences of illness. CONCLUSION: Survivors and partners in this study experienced uncertainty that persisted long after the completion of cancer treatment. The participants also described sources of uncertainty unique to this illness context. These results have important implications for health care providers and intervention developers and imply that chronic uncertainty should be managed throughout survivorship. IMPLICATIONS FOR CANCER SURVIVORS: The sources of uncertainty described in the current study have important implications for cancer survivors' management of uncertainty. Cancer survivors and their family members must first know the common sources of uncertainty to adaptively adjust to an uncertain survivorship trajectory. The present investigation provides insight into the uncertainty experiences of cancer survivors and implies that continued care may improve well-being after the completion of cancer treatment.
PURPOSE: Previous research has demonstrated the common experience of illness-related uncertainty; however, little research has explored the specific sources of uncertainty throughout cancer survivorship. The purpose of this study is to investigate the experience of uncertainty for cancer survivors and their partners. Thus, the following research question is posed: What are the sources of uncertainty in cancer survivorship for survivors and partners? METHOD: One-on-one interviews were conducted with 35 cancer survivors and 25 partners. Constant comparative methodologies were used to analyze the data. RESULTS:Participants described medical, personal, and social sources of uncertainty that persisted throughout survivorship. Medical sources of uncertainty included questions about the cancer diagnosis, treatment and prognosis. Personal sources of uncertainty included ambiguous valued identities and career-related questions. Social sources of uncertainty included unclear communicative, relational and familial consequences of illness. CONCLUSION: Survivors and partners in this study experienced uncertainty that persisted long after the completion of cancer treatment. The participants also described sources of uncertainty unique to this illness context. These results have important implications for health care providers and intervention developers and imply that chronic uncertainty should be managed throughout survivorship. IMPLICATIONS FOR CANCER SURVIVORS: The sources of uncertainty described in the current study have important implications for cancer survivors' management of uncertainty. Cancer survivors and their family members must first know the common sources of uncertainty to adaptively adjust to an uncertain survivorship trajectory. The present investigation provides insight into the uncertainty experiences of cancer survivors and implies that continued care may improve well-being after the completion of cancer treatment.
Authors: Deborah S Main; Carolyn T Nowels; Tia A Cavender; Martine Etschmaier; John F Steiner Journal: Psychooncology Date: 2005-11 Impact factor: 3.894
Authors: Dale E Brashers; Judith L Neidig; Jane A Russell; Linda W Cardillo; Stephen M Haas; Linda K Dobbs; Marie Garland; Bill McCartney; Sally Nemeth Journal: Issues Ment Health Nurs Date: 2003 Jul-Aug Impact factor: 1.835
Authors: Amy E Ustjanauskas; Gwendolyn P Quinn; Tonya M Pan; Maria Rivera; Coralia Vázquez-Otero; Danielle Ung; Richard G Roetzheim; Christine Laronga; Kenneth Johnson; Marilyn Norton; Claudia Carrizosa; Dariana Muñoz; Marissa Goldenstein; Sumayah Nuhaily; Kristen J Wells Journal: J Cancer Educ Date: 2017-12 Impact factor: 2.037
Authors: Ryan D Nipp; Areej El-Jawahri; Sara M D'Arpino; Andy Chan; Charn-Xin Fuh; P Connor Johnson; Daniel E Lage; Risa L Wong; William F Pirl; Lara Traeger; Barbara J Cashavelly; Vicki A Jackson; David P Ryan; Ephraim P Hochberg; Jennifer S Temel; Joseph A Greer Journal: Cancer Date: 2018-06-15 Impact factor: 6.860
Authors: Michelle Shayne; Eva Culakova; Michael T Milano; Sughosh Dhakal; Louis S Constine Journal: J Cancer Surviv Date: 2013-12-05 Impact factor: 4.442
Authors: Judy Huei-Yu Wang; Inez F Adams; Rena J Pasick; Scarlett L Gomez; Laura Allen; Grace X Ma; Michael X Lee; Ellen Huang Journal: Support Care Cancer Date: 2013-08-01 Impact factor: 3.359
Authors: Stelliana Goutzamanis; Joseph S Doyle; Alexander Thompson; Paul Dietze; Margaret Hellard; Peter Higgs Journal: BMC Infect Dis Date: 2018-04-02 Impact factor: 3.090